Affiliation:
1. University Hospital and Center for Integrated Oncology Cologne Cologne Germany
2. Division of Myeloma, Sylvester Comprehensive Cancer Center University of Miami Coral Gables Florida USA
Abstract
Novel therapies for multiple myeloma have substantially improved the prognosis, but before patients are able to benefit from treatment, a diagnosis must have been made. The Myeloma UK laboratory working group has developed a three‐part tool box to help primary care physicians to suspect myeloma despite mostly vague symptoms, to do the right tests and to derive the proper conclusions from the results.Commentary on: Drayson et al. Laboratory practice is central to earlier myeloma diagnosis; utilising a primary care diagnostic tool and laboratory guidelines integrated into haematology services. Br J Haematol 2024 (Online ahead of print). doi: 10.1111/bjh.19224.